Precision nutrition is gaining momentum as researchers look for better ways to prevent and manage inflammatory bowel disease, according to a new review published on 19 May 2026 in Nature Reviews Gastroenterology & Hepatology. The article argues that the growing burden of inflammatory bowel disease parallels changing dietary patterns linked to industrialization, making nutrition an increasingly important part of clinical care.
The review describes precision nutrition as a move beyond one-size-fits-all advice. Instead of offering the same dietary guidance to every patient, the authors propose tailoring recommendations to individual characteristics, including demographics, disease history and multiomics traits. The paper outlines a three-tier framework built around phenotype-based precision nutrition, omics-based precision nutrition and integrated precision nutrition.
Why individualized dietary advice matters
Inflammatory bowel disease includes Crohn’s disease and ulcerative colitis, and NHS guidance notes that it can cause severe tummy pain, diarrhoea and weight loss. The new review suggests that responses to food vary widely between patients, which may help explain why standard dietary advice does not work equally well for everyone. That variability is central to the case for more personalized nutrition strategies.
The authors say phenotype-based precision nutrition could use broad characteristics such as life stage, ethnicity and environmental exposures to refine dietary guidance for specific groups. Omics-based precision nutrition goes further by using genomics, metagenomics and metabolomics to identify biomarkers and microbial signatures that might distinguish people who respond to a diet from those who do not.
From biomarkers to continuous monitoring
According to the review, advances in large-scale longitudinal multiomics cohorts, biomarker detection and artificial intelligence are changing how researchers collect and interpret nutrition data. The authors also point to wearables, smart capsules and AI-driven processing as tools that could support dynamic monitoring and help translate nutritional science into practical care.
The review says the ultimate goal is an integrated model that can provide continuous, adaptive dietary optimization tailored to a person’s changing biological system. It adds that real-world use will require clear goals, predictive models and actionable strategies that clinicians and patients can actually follow over time.
What the review says this could mean in practice
In the authors’ view, precision nutrition in inflammatory bowel disease is meant to guide prevention as well as management. The review does not present this approach as a finished solution, but as a translational framework intended to move research and clinical practice closer together.
For now, the paper positions individualized dietary care as an evolving field rather than a replacement for current treatment. But it signals that nutrition may become more central to inflammatory bowel disease care as researchers learn more about how different bodies respond to food.
Read more on the original review at Nature Reviews Gastroenterology & Hepatology and related NHS background on inflammatory bowel disease at NHS.
